Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53

Blood

Volumn 90, Issue 12, 1997, Pages 4924-4932

  Mori, Naoki ^a   Kashanchi, Fatah ^b   Prager, Diane ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MUTANT PROTEIN; PROTEIN P53; TATA BINDING PROTEIN; TAX PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T CELL LEUKEMIA; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; VIRUS TRANSCRIPTION;

EID: 0031454222     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4924     Document Type: Article

References (58)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415, 1980
2. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031, 1982
3. Kimata JT, Wong FH, Wang JJ, Ratner L: Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204:656, 1994
4. Hahn B, Gallo RC, Franchini G, Popovic M, Aoki T, Salahuddin SZ, Markham PD, Staal LW: Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro. Mol Biol Med 2:29, 1984
5. Kimata JT, Ratner L: Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J Virol 65:4398, 1991
6. Robert-Guroff M, Nakao Y, Notake K, Ito Y, Sliski A, Gallo RC: Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. Science 215:975, 1982
7. Seiki M, Hattori S, Hirayama Y, Yoshida M: Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 80:3618, 1983
8. Seiki M, Eddy R, Shows TB, Yoshida M: Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature 309:640, 1984
9. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohno K: Multistep carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 80:191, 1989
10. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855, 1994
11. Nagai H, Kinoshita T, Imamura J, Murakami Y, Hayashi K, Mukai K, Ikeda S, Tobinai K, Saito H, Shimoyama M, Shimotohno K: Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn J Cancer Res 82:1421, 1991
12. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP: Mutations of the p53 gene in adult T-cell leukemia. Blood 79:477, 1992
13. Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM: Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 80:3205, 1992
14. Sugito S, Yamato K, Sameshima Y, Yokota J, Yano S, Miyoshi I: Adult T-cell leukemia: Structures and expression of the p53 gene. Int J Cancer 49:880, 1991
15. Linzer DIH, Levine AJ: Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cell 17:43, 1979
16. Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus E1b 58-kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54-kd cellular protein in transformed cells. Cell 28:387, 1982
17. Oren M, Maltzman W, Levine AJ: Post-translational regulation of the 54 K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1:101, 1981
18. Reich NC, Levine AJ: Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308:199, 1984
19. Rogel A, Popliker M, Webb CG, Oren M: p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5:2851, 1985
20. Lubbert M, Miller CW, Kahan J, Koeffler HP: Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes. Oncogene 4:643, 1989
21. Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN: Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 8:3029, 1993
22. Yamato K, Oka T, Hiroi M, Iwahara Y, Sugito S, Tsuchida N, Miyoshi I: Aberrant expression of p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells. Jpn J Cancer Res 84:4, 1993
23. Gartenhaus RB, Wang P: Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia 9:2082, 1995
24. waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood 88:1551, 1996
25. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M: Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87:1071, 1990
26. Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar M-C, Sodroski JG, Haseltine WA: Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci USA 86:3351, 1989
27. Grossman WJ, Kimata JT, Wong F-H, Zutter M, Ley TJ, Ratner L: Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 92:1057, 1995
28. Paskalis H, Felber BK, Pavlakis GN: Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci USA 83:6558, 1986
29. Rosen CA, Sodroski JG, Haseltine WA: Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. Proc Natl Acad Sci USA 82:6502, 1985
30. Sodroski JG, Rosen CA, Haseltine WA: Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381, 1984
31. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 84:5389, 1987
32. Mori N, Prager D: Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87:3410, 1996
33. Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto S, Eto S: Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: Evidence for the involvement of NF-κB. Blood 84:2904, 1994
34. Mori N, Murakami S, Oda S, Prager D, Eto S: Production of interleukin 8 in adult T-cell leukemia cells: Possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax. Cancer Res 55:3592, 1995
35. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D: Interleukin-10 gene expression in adult T-cell leukemia. Blood 88:1035, 1996
36. Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen ISY, Rosenblatt JD: Activation of the GM-CSF promoter by HTLV-I and HTLV-II tax proteins. Oncogene 4:671, 1989
37. Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M: HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 6:1023, 1991
38. Zambetti GP, Bargonetti J, Walker K, Prives C, Levine AJ: Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev 6:1143, 1992
39. Mack DH, Vartikar J, Pipas JM, Laimins LA: Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281, 1993
40. Agoff SN, Hou J, Linzer DIH, Wu B: Regulation of the human hsp70 promoter by p53. Science 259:84, 1993
41. Uittenbogaard MN, Giebler HA, Reisman D, Nyborg JK: Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem 270:28503, 1995
42. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG: Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55:409, 1980
43. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770, 1981
44. Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, Kishimoto T: Structure of expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 6:2939, 1987
45. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912, 1990
46. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B: Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827, 1992
47. Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S, Seyama T: Gain-of-function p53 mutations enhance alteration of the T-cell receptor following x-irradiation, independently of the cell cycle and cell survival. Cancer Res 56:3862, 1996
48. Koeffler HP, Miller C, Nicolson MA, Ranyard J, Bosselman RA: Increased expression of p53 protein in human leukemia cells. Proc Natl Acad Sci USA 83:4035, 1986
49. Cheng J, Haas M: Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502, 1990
50. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y, Hirai H: Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79:2378, 1992
51. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1:45, 1992
52. x of HTLV-I. EMBO J 5:713, 1986
53. Shimotohno K, Takano M, Teruuchi T, Miwa M: Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc Natl Acad Sci USA 83:8112, 1986
54. Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T: Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028, 1992
55. Caron C, Rousset R, Beraud C, Moncollin V, Egly J-M, Jalinot P: Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. EMBO J 12:4269, 1993
56. Zhao L-J, Giam C-Z: Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 89:7070, 1992
57. Wagner S, Green MR: HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395, 1993
58. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineages. Blood 84:2391, 1994